# nSTRIDE APS Versus Hyaluronic Acid for Knee Osteoarthritis

> **NCT03182374** · NA · COMPLETED · sponsor: **Zimmer Biomet** · enrollment: 252 (actual)

## Conditions studied

- Osteoarthritis, Knee

## Interventions

- **DEVICE:** nSTRIDE APS
- **DEVICE:** Synvisc-One

## Key facts

- **NCT ID:** NCT03182374
- **Lead sponsor:** Zimmer Biomet
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-14
- **Primary completion:** 2019-09-30
- **Final completion:** 2023-01-30
- **Target enrollment:** 252 (ACTUAL)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03182374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03182374, "nSTRIDE APS Versus Hyaluronic Acid for Knee Osteoarthritis". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03182374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*